Five more U.S. states filed lawsuits accusing Purdue Pharma of contributing to the nationwide opioid epidemic by illegally marketing and selling OxyContin, according to Reuters.
Pharmacy
The Metropolitan Museum of Art will stop accepting donations from the family that owns OxyContin maker Purdue Pharma, according to The New York Times.
CVS Health is launching a new program that will require third-party testing on all vitamins and supplements sold at its stores to ensure accuracy of the dietary ingredients and guard against contamination.
Gilead Science CEO Daniel O'Day will testify May 16 on Capitol Hill in front of a House committee over the pricing for its HIV prevention pill, according to STAT.
In an effort to lower prescription drug costs in the U.S., CMS issued a new guidance May 15 to limit the prevalence of spread pricing in Medicaid managed care plans.
Advertisement
Pennsylvania Attorney General Josh Shapiro accused Purdue Pharma of fueling the opioid epidemic in the state in a lawsuit filed May 14, according to The Hill.
ProvideGx, a subsidiary of Premier, will collaborate with Fresenius Kabi to help mitigate national shortages of five generic injectable medications.
Civica Rx, the nonprofit generic drugmaker formed by a group of health systems, will begin by distributing two essential antibiotics, the company announced May 15.
Johnson & Johnson and Teva Pharmaceuticals lost a last-minute bid to escape an opioid lawsuit brought against them by the state of Oklahoma, according to Reuters.
Kentucky is suing three insulin makers — Eli Lilly, Sanofi and Novo Nordisk — over alleged price-gouging, according to The Hill. The state is the latest to sue insulin manufacturers over the pricing of the product.